Intensive cholesterol-lowering treatment: No significantly better outcomes
Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin treatment alone in patients ...
Aug 29, 2016
0
0